Behavioral Support Intervention For Smokeless Tobacco Cessation At A Dental Setting
Trial Snapshot
- Phase
- Phase 3 4
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 100
- Locations
- 1
- Primary Endpoint
- Abstinence of smokeless tobacco use
Study Overview
Brief Summary
The prevalence of smokeless tobacco (SLT) use is predominant in India. It accounts for some of the highest rates of smokeless tobacco use and Oral cancer in the world. SLT is consumed by more than 350 million individuals worldwide; approximately 85% of users are concentrated in South and South-East Asia. In these low-resource settings where SLT is culturally ingrained, it remains cheap, widely available and poorly regulated. South and South-East Asian SLT products often contain stimulants and flavorings that enhance flavor and addictiveness. On the other hand, their preparation methods induce high levels of free nicotine, Tobacco Specific Nitrosamines and heavy metals. Due to their composition SLT products are highly addictive and toxic. More than 40 types of SLT like paan, paan masala, khaini, zarda, mawa, gutka and mishri and gudakhu are used in chewing, snuffing and applying in teeth and gums.
SLT cessation intervention-based research needs encouragement; Behavioral interventions have been proven to be an efficacious and feasible modality for tobacco cessation in all setting. Sensitization and imparting of training regarding the same use prevention and cessation-related programs need to be encouraged. Patients who visit the dental hospital may not be motivated to quit the habit of tobacco chewing. Tobacco smokers who receive intervention from oral health professionals in the dental office are more likely to quit. Nevertheless, due to the small number of trials evaluated, it is difficult to establish the most important component of the cessation intervention.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Masking
- Outcome Assessor Blinded
Eligibility Criteria
- Ages
- 18.00 Year(s) to 70.00 Year(s) (—)
- Sex
- All
Inclusion Criteria
- •All participants over the age of 18 who had been using smokeless tobacco exclusively for at least 6 months prior to the visit.
Exclusion Criteria
- •Participants with any acute or chronic disease that prevented them from effectively participating in the experiment, as well as those under treatment for psychiatric disorders, were excluded from the study.
Outcomes
Primary Outcomes
Abstinence of smokeless tobacco use
Time Frame: 1 week, 6 weeks, 9 weeks, 12 weeks and 24 weeks
Secondary Outcomes
- Urine cotinine test(Baseline & 24 weeks)
Investigators
Dr Smitarani Priyadarshini
Institute of Dental Sciences
